Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment of Schizophrenia”

1,267 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,267 results

Large-scale testing (Phase 3)UnknownNCT00141947
What this trial is testing

Bexarotene Treatment in Schizophrenia

Who this might be right for
Schizophrenia
Beersheva Mental Health Center 15
Large-scale testing (Phase 3)Ended earlyNCT01908192
What this trial is testing

Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen®

Who this might be right for
Schizophrenia
SyneuRx International (Taiwan) Corp 60
Post-approval studies (Phase 4)Study completedNCT00524043
What this trial is testing

An Efficacy and Safety Study of One Dosage of Paliperidone Extended Release (ER) in Treating Patients With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 201
Post-approval studies (Phase 4)UnknownNCT02282085
What this trial is testing

Treatment Study Comparing Aripiprazole Once Monthly With Standard of Care Medication in Outpatients With Schizophrenia

Who this might be right for
Schizophrenia
Matt Byerly 200
Large-scale testing (Phase 3)Study completedNCT00086593
What this trial is testing

Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia

Who this might be right for
Schizophrenia
GlaxoSmithKline 209
Not applicableUnknownNCT04335916
What this trial is testing

Survey on Pre-ECT Evaluation and ECT Application

Who this might be right for
DepressionCatatoniaSchizophrenia+3 more
Klinički Bolnički Centar Zagreb 30
Post-approval studies (Phase 4)WithdrawnNCT02286206
What this trial is testing

Study of the Effect of Dosing on Clozapine Levels

Who this might be right for
Psychotic DisordersSchizophrenia
University of British Columbia
Not applicableStudy completedNCT05300633
What this trial is testing

Community Reinforcement Approach and Family Training for Substance Use in Early Psychosis Intervention

Who this might be right for
PsychosisSchizophrenia and Related DisordersSchizophrenia Spectrum and Other Psychotic Disorders+2 more
Centre for Addiction and Mental Health 14
Post-approval studies (Phase 4)Study completedNCT00255515
What this trial is testing

Seroquel® Combined With Cognitive Remediation Therapy to Conventional Treatment in Patients With Schizophrenia

Who this might be right for
Schizophrenia
AstraZeneca 85
Not applicableStudy completedNCT06199817
What this trial is testing

The Effect Of Multiple Occupational Therapies On Functional Remission And Subjective Recovery For Schizophrenia

Who this might be right for
Occupational TherapySchizophreniaRemission+1 more
Ege University 55
Large-scale testing (Phase 3)Study completedNCT00299715
What this trial is testing

Evaluate the Efficacy and Safety of Three Fixed Doses of Extended-release Paliperidone in Subjects With Bipolar I Disorder

Who this might be right for
Bipolar DisorderMood Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 473
Not applicableUnknownNCT01510015
What this trial is testing

Evaluation of the Effects of Treatment of Psycho-stimulant and Cannabis-dependent Users in Israel

Who this might be right for
Cannabis DependencePsychostimulant Dependence
Tel-Aviv Sourasky Medical Center 100
Not applicableActive Not RecruitingNCT05726617
What this trial is testing

Avatar Intervention for the Treatment of Cannabis Use Disorder in Patients With Severe Mental Health Disorders

Who this might be right for
Psychotic DisordersCannabis Use DisorderMental Health Disorder
Ciusss de L'Est de l'Île de Montréal 32
Early research (Phase 1)Study completedNCT01429740
What this trial is testing

The Safety, Tolerability And Pharmacokinetics Of Single Doses Of PF-05180999 In Healthy Adults

Who this might be right for
Schizophrenia
Pfizer 29
Large-scale testing (Phase 3)Study completedNCT03238326
What this trial is testing

Safety and Tolerability of Open-Label Flexible-dose Brexpiprazole as Maintenance Treatment in Adolescents With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 295
Not applicableActive Not RecruitingNCT07351240
What this trial is testing

The Acupuncture Treatment Effect in Patients With Schizophrenia

Who this might be right for
Mental Health
Calo Psychiatric Center 100
Testing effectiveness (Phase 2)WithdrawnNCT04761861
What this trial is testing

Vildagliptin for Treatment of Antipsychotic-induced Dyslipidemia

Who this might be right for
SchizophreniaDyslipidemias
Sadat City University
Large-scale testing (Phase 3)Study completedNCT01235559
What this trial is testing

RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25305)

Who this might be right for
Schizophrenia
Hoffmann-La Roche 604
Not applicableStudy completedNCT05603260
What this trial is testing

Imagery Interventions for Auditory Vocal Hallucinations

Who this might be right for
Auditory HallucinationHearing Voices When No One is TalkingPsychosis
Hella Janssen 32
Not applicableStudy completedNCT05438160
What this trial is testing

Exploratory Study of a Digital Therapeutics in People With Schizophrenia

Who this might be right for
Schizophrenia
Click Therapeutics, Inc. 48
Load More Results